Study helps lay the foundations for a future of “smart” tissue therapeutics that can be scaled to a patient’s needs.

A new liver tissue engineering strategy called BOOST could help bridge the transplant gap for thousands of end-stage liver ...

In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...

In patients developing end-stage liver disease, the damage has become too severe for the liver’s normally extraordinary ...

In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...

Breast cancer remains one of the most common malignancies in women worldwide, and although overall survival has improved in recent decades, metastatic ...

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is proud to announce the launch of its new line of Alkali-Tolerant AAV Affinity Agarose Resins. Specifically ...

In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary regenerative ...

Ferrocene-modified covalent organic frameworks combine sonodynamic therapy with immune activation to suppress primary breast ...

A newly engineered biochar material may offer a powerful and sustainable way to clean up toxic metals from polluted water and ...

Nanobiotechnology is driving a new era in the life sciences, where the intersection of engineered nanomaterials and biology is catalyzing major advances in ...

Functional coatings improve polymer surfaces by adding barrier protection, chemical resistance, hydrophobicity, conductivity, ...